Twinbeech Capital LP Reata Pharmaceuticals Inc Transaction History

Twinbeech Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $575,013 - $1.01 Million	-27,765 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $420,604 - $690,544	-17,438 Reduced 38.58%	27,765 $910,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $1.16 Million - $5.02 Million	45,203 New	45,203 $1.19 Million
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $764,493 - $1.07 Million	-6,053 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $751,540 - $1.5 Million	6,053 New	6,053 $874,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.